JP2008056661A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008056661A5 JP2008056661A5 JP2007194145A JP2007194145A JP2008056661A5 JP 2008056661 A5 JP2008056661 A5 JP 2008056661A5 JP 2007194145 A JP2007194145 A JP 2007194145A JP 2007194145 A JP2007194145 A JP 2007194145A JP 2008056661 A5 JP2008056661 A5 JP 2008056661A5
- Authority
- JP
- Japan
- Prior art keywords
- hyperuricemia
- disease caused
- composition containing
- containing biotin
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 201000001431 Hyperuricemia Diseases 0.000 claims 4
- 229960002685 biotin Drugs 0.000 claims 4
- 235000020958 biotin Nutrition 0.000 claims 4
- 239000011616 biotin Substances 0.000 claims 4
- 206010007027 Calculus urinary Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 claims 1
- 206010034568 Peripheral coldness Diseases 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 1
- 208000009911 Urinary Calculi Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000034783 hypoesthesia Diseases 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 208000026843 stiff neck Diseases 0.000 claims 1
- 229940116269 uric acid Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007194145A JP5186145B2 (ja) | 2006-08-02 | 2007-07-26 | 高尿酸血症又はこれに起因する疾患の予防又は治療のための医薬又は食品組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006211063 | 2006-08-02 | ||
| JP2006211063 | 2006-08-02 | ||
| JP2007194145A JP5186145B2 (ja) | 2006-08-02 | 2007-07-26 | 高尿酸血症又はこれに起因する疾患の予防又は治療のための医薬又は食品組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008056661A JP2008056661A (ja) | 2008-03-13 |
| JP2008056661A5 true JP2008056661A5 (enExample) | 2010-07-29 |
| JP5186145B2 JP5186145B2 (ja) | 2013-04-17 |
Family
ID=39239831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007194145A Active JP5186145B2 (ja) | 2006-08-02 | 2007-07-26 | 高尿酸血症又はこれに起因する疾患の予防又は治療のための医薬又は食品組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5186145B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6719475B2 (ja) * | 2015-09-04 | 2020-07-08 | サントリーホールディングス株式会社 | ウレアーゼ活性阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006089392A (ja) * | 2004-09-22 | 2006-04-06 | Tohoku Univ | 生活習慣病改善食品および生活習慣病治療薬 |
-
2007
- 2007-07-26 JP JP2007194145A patent/JP5186145B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008027584A3 (en) | 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase | |
| JP2009542263A5 (enExample) | ||
| JP2010522185A5 (enExample) | ||
| PL2018184T3 (pl) | Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego | |
| JP2010514554A5 (enExample) | ||
| EA201101189A1 (ru) | Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии | |
| WO2010029089A3 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| JP2007525551A5 (enExample) | ||
| JP2012184234A5 (enExample) | ||
| JP2013507408A5 (enExample) | ||
| WO2010077339A3 (en) | β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF | |
| EP2140882A4 (en) | MEDICINE FOR THE TREATMENT OF LUNG DISEASES | |
| MX2007008141A (es) | Composicion farmaceutica de sustancias labiles en medio acido. | |
| JP2009519974A5 (enExample) | ||
| JP2008056661A5 (enExample) | ||
| JP2009523791A5 (enExample) | ||
| JP2012525422A5 (enExample) | ||
| JP2008031164A5 (enExample) | ||
| WO2009091134A3 (en) | Pharmaceutical composition for sepsis and septic shock | |
| JP2008504228A5 (enExample) | ||
| IT1394378B1 (it) | Banco cassa flessibile, con possibilita' di trasformazione rapida e semplificata dal normale uso assistito a quello self e viceversa. | |
| JP2009538982A5 (enExample) | ||
| JP2008143899A5 (enExample) | ||
| ZA201004800B (en) | Compound (r)-n*6*-ethyl-6,7-dihydro-5h-indeno(5,6-d)thiazole-2,6-diamine and the use as antipsychotics | |
| JP2004262929A5 (enExample) |